13F Pro13F Pro

Odyssean, LLC

Institutional InvestorSimilar funds →SEC EDGAR: CIK 2092853
Institutional-grade research for retail investors

Sector Allocation

  • Technology23.3%$143.4M
  • Financials19.0%$116.7M
  • Healthcare14.8%$91.2M
  • Industrials8.1%$49.8M
  • Real Estate7.4%$45.5M
  • Utilities5.8%$36.0M
  • Consumer Discretionary5.6%$34.7M
  • Energy4.9%$29.9M
  • Communication Services4.4%$27.1M
  • Consumer Staples4.0%$24.6M

AUM History

13fpro.ai/research/fund/odyssean-llc-2092853

Largest positions — Q2 2026

Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.

13fpro.ai/research/fund/odyssean-llc-2092853

Odyssean, LLC 13F holdings — Q2 2026

$614.9M portfolio (+124.5% QoQ) · 485 holdings · Q2 2026 13F · top 10 are 6% of the stock portfolio

All holdings — Odyssean, LLC (Q2 2026)

485 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.

Company
VIK$VIKViking Holdings Ltd$3.4M+55%
MEDP$MEDPMedpace Holdings, Inc.$3.4MNew
TOST$TOSTToast, Inc.$3.3M+144%
AHR$AHRAmerican Healthcare REIT, Inc.$3.3M+121%
NIC$NICNICOLET BANKSHARES INC$3.3M+101%
VEEV$VEEVVEEVA SYSTEMS INC$3.3M+144%
GRBK$GRBKGreen Brick Partners, Inc.$3.3M+93%
ESNT$ESNTEssent Group Ltd.$3.3M+102%
MSGE$MSGEMadison Square Garden Entertainment Corp.$3.3M+60%
IPAR$IPARINTERPARFUMS INC$3.3M+87%
EEFT$EEFTEURONET WORLDWIDE, INC.$3.3M+121%
NU$NUNu Holdings Ltd.$3.3MNew
XYZ$XYZBlock, Inc.$3.2M+92%
HCI$HCIHCI Group, Inc.$3.2M+112%
DELL$DELLDell Technologies Inc.$3.2M-15%

What changed in Q2 2026

Against the previous quarter's 13F: 165 new, 189 added to, 29 trimmed, 99 sold out. Share-count changes; largest moves by dollar size first.

New positions (165)

  • CLDX$CLDXCelldex Therapeutics, Inc.$3.5M

    first bought this quarter

  • DASH$DASHDoorDash, Inc.$3.5M

    first bought this quarter

  • MEDP$MEDPMedpace Holdings, Inc.$3.4M

    first bought this quarter

  • NU$NUNu Holdings Ltd.$3.3M

    first bought this quarter

  • DNLI$DNLIDenali Therapeutics Inc.$3.2M

    first bought this quarter

  • CRNX$CRNXCrinetics Pharmaceuticals, Inc.$3.2M

    first bought this quarter

+159 more in the Excel export

Added to (189)

  • IDYA$IDYAIDEAYA Biosciences, Inc.+572%

    now $3.8M · held 3+ qtrs

  • RDNT$RDNTRadNet, Inc.+378%

    now $3.2M · held 2 qtrs, 2 adds in a row

  • PCVX$PCVXVaxcyte, Inc.+211%

    now $3.6M · held 3+ qtrs, 2 adds in a row

  • CVX$CVXCHEVRON CORP+1515%

    now $2.6M · held 2 qtrs, 2 adds in a row

  • XOM.R34088$XOM.R34088EXXON MOBIL CORP+633%

    now $2.8M · held 2 qtrs, 2 adds in a row

  • KYMR$KYMRKymera Therapeutics, Inc.+133%

    now $4.0M · held 3+ qtrs, 2 adds in a row

+183 more in the Excel export

Trimmed (29)

  • DELL$DELLDell Technologies Inc.-15%

    now $3.2M · held 3+ qtrs

  • OKTA$OKTAOkta, Inc.-19%

    now $1.8M · held 3+ qtrs

  • RPAY$RPAYRepay Holdings Corp-63%

    now $226K

  • VICR$VICRVICOR CORP-7%

    now $2.4M · held 3+ qtrs

  • SANM$SANMSANMINA CORP-4%

    now $2.1M · held 3+ qtrs

  • FTNT$FTNTFortinet, Inc.-3%

    now $2.7M · held 3+ qtrs

+23 more in the Excel export

Sold out (99)

  • REGN$REGNREGENERON PHARMACEUTICALS, INC.was $1.5M

    held 2+ qtrs

  • AL$ALAIR LEASE CORPwas $1.5M

    held 2+ qtrs

  • TPH$TPHTri Pointe Homes, Inc.was $1.5M

    held 2+ qtrs

  • MASI$MASIMASIMO CORPwas $1.4M

    held 1 qtr

  • NLY$NLYANNALY CAPITAL MANAGEMENT INCwas $1.4M

    held 1 qtr

  • CPT$CPTCAMDEN PROPERTY TRUSTwas $1.3M

+93 more in the Excel export

Firm AUM (Form ADV): $373.3M as of 2025-12-31 · SEC IAPD

Share

Holdings by quarter

Every 13F Odyssean, LLC has filed, 2 earlier quarters. Pick one to see what it held then.

Email me the moment this fund files its next 13FPro

Is it too late to follow Odyssean?

Q2 2026 13F filed with the SEC on Aug 14, 2026. Prices are closing prices as of Oct 27, 2026.

Average quality of Odyssean's top 20 holdings: 54/100 (our AI quality score, weighted by position size; 17 of the 20 are scored)

Top 10 since filing

-13.7%

Value-weighted move of the 10 largest stock positions

Turnover

11%

Last quarter

Top 10 weight

6%

Share of the stock portfolio in its 10 largest positions

Held 4+ quarters

0%

Share of portfolio value in positions held a year or more

Highest-quality names it owns(among its 100 largest positions)

The 8 highest-scoring companies in this portfolio are a Pro feature.

How these are measured
  • Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
  • Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
  • Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q4 2025 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
  • Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
  • Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.

Portfolio Overview

Odyssean, LLC disclosed 485 positions worth $614.9M in its Form 13F-HR for Q2 2026, led by $RARE (Ultragenyx Pharmaceutical Inc.) at 0.7% of the equity portfolio, followed by $KYMR and $IDYA. During the quarter the fund opened 165 new positions and exited 99 — including a new stake in $CLDX and a full exit from $REGN. The portfolio is most concentrated in Technology (23.3% of disclosed assets). All figures are sourced directly from Odyssean, LLC’s Form 13F-HR filing with the SEC under CIK 2092853.

Funds like this

managers whose biggest positions overlap Odyssean's
BAKER BROS. ADVISORS LP$19.96B 13F book · 6 shared top holdingsKYMRIDYADNLICRNXEVENTIDE ASSET MANAGEMENT, LLC$7.48B 13F book · 5 shared top holdingsKYMRPCVXMIRMTOSTBellevue Group AG$4.75B 13F book · 5 shared top holdingsRAREPCVXCLDXKRYSGILDER GAGNON HOWE & CO LLC$9.69B 13F book · 4 shared top holdingsAFRMDASHTOSTABNBNikko Asset Management Americas, Inc.$7.75B 13F book · 4 shared top holdingsDASHTOSTNUXYZCapital Impact Advisors, LLC$1.78B 13F book · 5 shared top holdingsAFRMDASHMEDPTOST

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

Berkshire HathawayBridgewater AssociatesCitadel AdvisorsRenaissance TechnologiesTwo Sigma InvestmentsDE Shaw & CoMillennium ManagementAQR Capital ManagementPoint72 Asset ManagementTiger Global ManagementVanguard GroupBlackRock

to search all 8,700+ institutional filers.

AI-Powered Hedge Fund Analysis: Odyssean, LLC

13F Pro is an AI hedge fund tracker and stock research platform. For Odyssean, LLC (SEC CIK: 2092853), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in Odyssean, LLC's portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.